HIV-1 Vpr: genetic diversity and functional features from the perspective of structure.
RNA viruses are well known for the enormous genetic variation. Retroviruses share this feature with other RNA viruses, and human immunodeficiency virus type 1 (HIV-1) has been extensively investigated in this regard. Based on the DNA sequence analysis, HIV-1 has been classified into three groups; M, N, and O, with viral subtypes in each group. While the genetic variation between viral isolates has been documented throughout the genome, specifically, the env gene exhibits high variation. Analysis of the env gene from the sequential samples from HIV-1-infected patients reveals variation in the range of 1% per year. The variation observed in individual HIV-1 genes in the form of changes at the nucleotide level, as expected, should result in one of the possible scenarios: (1) no change in the amino acid, (2) conservative change in the amino acid, (3) nonconservative change in the amino acid, and (4) premature stop codon resulting in a truncated protein. Hence, it is likely that the variation may impact on the function of the protein, depending on the nature of the mutation. The goal of this review is to summarize the polymorphisms in Vpr using the available sequence information and discuss their effects on the functions of Vpr from the point of view of its structure. The data generated by several groups provide a base for understanding the consequences of natural polymorphisms in specific regions of the Vpr molecule. However, it is also clear that secondary changes (second site or compensatory mutations) may modify the effect of a specific mutation and a comprehensive analysis is needed to delineate the role of specific residues in Vpr molecule. This is an area which, we hope, will attract investigators for further studies, and may provide information for understanding the molecular basis of Vpr functions.
Tungaturthi
Parithosh K
PK
Department of Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
Sawaya
Bassel E
BE
Ayyavoo
Velpandi
V
Murali
Ramachandran
R
Srinivasan
Alagarsamy
A
D000163:Acquired Immunodeficiency Syndrome / Q000503:physiopathology*; D000595:Amino Acid Sequence; D017209:Apoptosis / Q000502:physiology; D002453:Cell Cycle / Q000502:physiology*; D016336:Gene Products, vpr / Q000235:genetics* / Q000378:metabolism / Q000502:physiology*; D014644:Genetic Variation; D015497:HIV-1 / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D017434:Protein Structure, Tertiary; D015533:Transcriptional Activation / Q000235:genetics; D054325:vpr Gene Products, Human Immunodeficiency Virus
D016336:Gene Products, vpr; D054325:vpr Gene Products, Human Immunodeficiency Virus